 BOULDER, Colo.--BUSINESS WIRE--Edgewise Therapeutics, Inc., NASDAQ: EWTX, a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies for the treatment of rare muscle disorders, announced today that members of its senior management team will participate in the following upcoming investor conferences: Jefferies Healthcare Conference Presentation: Friday, June 10, 2022, at 10 am ET Goldman Sachs Annual Global Healthcare Conference Fire Side C 